Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine infusion and postoperative sleep quality in thyroid surgery
ChiCTR2300073022Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sleep disorder, anxiety disorder, major depressive disorder (MDD) and 1 more comparing Esketamine infusion arm with Saline placebo arm (2 arms). Primary endpoint: Sleep quality. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorderanxiety disordermajor depressive disorder (MDD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300073022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073022.